Issue 18/2022
Content (9 Articles)
Acknowledgement to Referees
- Acknowledgement to Referees
The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis
- Tuberculosis
- Review Article
Brett D. Edwards, Stephen K. Field
Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study
- Febuxostat
- Original Research Article
Qiang Tong, Yu Du, Ran Cui, Miao Chen, Shiow-Ing Wang, James Cheng-Chung Wei, Sheng-Ming Dai
Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
- Open Access
- Eculizumab
- Adis Drug Evaluation
Young-A Heo
Comment on: “Global Consumption Trend of Antifungal Agents in Humans from 2008 to 2018: Data from 65 Middle‐ and High‐Income Countries”
- Itraconazole
- Letter to the Editor
David W. Denning
Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”
- Itraconazole
- Letter to the Editor
Swathi Pathadka, Vincent K. C. Yan, Chin Fen Neoh, Daoud Al-Badriyeh, David C. M. Kong, Monica A. Slavin, Benjamin J. Cowling, Ivan F. N. Hung, Ian C. K. Wong, Esther W. Chan
Correction: Teprotumumab: A Review in Thyroid Eye Disease
- Open Access
- Correction
Tina Nie, Yvette N. Lamb